{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T11:08:48Z","timestamp":1783940928210,"version":"3.55.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-41960-y","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T09:25:47Z","timestamp":1778577947000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["1,3,4 oxadiazole derivative attenuates neurotransmitter-mediated inflammatory response in EAE model of multiple sclerosis"],"prefix":"10.1038","volume":"16","author":[{"given":"Syeda Rida","family":"Zainab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jehan Zeb","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humaira","family":"Nadeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Khalid","family":"Tipu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaheer","family":"Ul-Haq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihsan Ul","family":"Haq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem","family":"Irshad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"41960_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.782599","volume":"12","author":"EA M\u00f6ck","year":"2021","unstructured":"M\u00f6ck, E. A., Honkonen, E. & Airas, L. Synaptic loss in multiple sclerosis: A systematic review of human post-mortem studies. Front. Neurol. 12, 782599 (2021).","journal-title":"Front. Neurol."},{"key":"41960_CR2","doi-asserted-by":"publisher","first-page":"1024058","DOI":"10.3389\/fnmol.2022.1024058","volume":"15","author":"RR Voskuhl","year":"2022","unstructured":"Voskuhl, R. R. & Mackenzie-Graham, A. Chronic experimental autoimmune encephalomyelitis is an excellent model to study neuroaxonal degeneration in multiple sclerosis. Front. Mol. Neurosci. 15, 1024058 (2022).","journal-title":"Front. Mol. Neurosci."},{"key":"41960_CR3","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton, C. et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS. Mult. Scler. J. 26, 1816\u20131821 (2020).","journal-title":"Mult. Scler. J."},{"key":"41960_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1454","volume":"12","author":"A Afrasiabi","year":"2023","unstructured":"Afrasiabi, A., Ahlenstiel, C., Swaminathan, S. & Parnell, G. P. The interaction between Epstein\u2013Barr virus and multiple sclerosis genetic risk loci: Insights into disease pathogenesis and therapeutic opportunities. Clin. Transl. Immunol. 12, e1454 (2023).","journal-title":"Clin. Transl. Immunol."},{"key":"41960_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.neuroscience.2024.12.029","volume":"567","author":"SR Zainab","year":"2025","unstructured":"Zainab, S. R., Khan, J. Z., Tipu, M. K., Jahan, F. & Irshad, N. A review on multiple sclerosis: Unravelling the complexities of pathogenesis, progression, mechanisms and therapeutic innovations. Neuroscience 567, 133\u2013149 (2025).","journal-title":"Neuroscience"},{"key":"41960_CR6","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/S1474-4422(20)30277-5","volume":"19","author":"RH Benedict","year":"2020","unstructured":"Benedict, R. H., Amato, M. P., Deluca, J. & Geurts, J. J. Cognitive impairment in multiple sclerosis: Clinical management, MRI, and therapeutic avenues. Lancet Neurol. 19, 860\u2013871 (2020).","journal-title":"Lancet Neurol."},{"key":"41960_CR7","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1021\/acschemneuro.2c00589","volume":"14","author":"E Akyuz","year":"2023","unstructured":"Akyuz, E., Celik, B. R., Aslan, F. S., Sahin, H. & Angelopoulou, E. Exploring the role of neurotransmitters in multiple sclerosis: An expanded review. ACS Chem. Neurosci. 14, 527\u2013553 (2023).","journal-title":"ACS Chem. Neurosci."},{"key":"41960_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1442694","volume":"15","author":"X Jiang","year":"2024","unstructured":"Jiang, X., Zhang, H., Liu, Y., Sun, B. & Mu, G. Global perspectives on the contribution of B cells to multiple sclerosis: An in-depth examination and evaluation. Front. Immunol. 15, 1442694 (2024).","journal-title":"Front. Immunol."},{"key":"41960_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/medsci5040023","volume":"5","author":"P Palle","year":"2017","unstructured":"Palle, P., Monaghan, K. L., Milne, S. M. & Wan, E. C. Cytokine signaling in multiple sclerosis and its therapeutic applications. Medical sciences 5, 23 (2017).","journal-title":"Medical sciences"},{"key":"41960_CR10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.nbd.2014.11.022","volume":"74","author":"A Gentile","year":"2015","unstructured":"Gentile, A. et al. Dopaminergic dysfunction is associated with IL-1\u03b2-dependent mood alterations in experimental autoimmune encephalomyelitis. Neurobiol. Dis. 74, 347\u2013358 (2015).","journal-title":"Neurobiol. Dis."},{"key":"41960_CR11","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.neuroimage.2017.01.033","volume":"157","author":"JC Nantes","year":"2017","unstructured":"Nantes, J. C. et al. GABA and glutamate levels correlate with MTR and clinical disability: Insights from multiple sclerosis. Neuroimage 157, 705\u2013715 (2017).","journal-title":"Neuroimage"},{"key":"41960_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2021.109610","volume":"137","author":"J Arm","year":"2021","unstructured":"Arm, J. et al. Altered in vivo brain GABA and glutamate levels are associated with multiple sclerosis central fatigue. Eur. J. Radiol. 137, 109610 (2021).","journal-title":"Eur. J. Radiol."},{"key":"41960_CR13","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/S1474-4422(16)30165-X","volume":"15","author":"R Macrez","year":"2016","unstructured":"Macrez, R., Stys, P. K., Vivien, D., Lipton, S. A. & Docagne, F. Mechanisms of glutamate toxicity in multiple sclerosis: Biomarker and therapeutic opportunities. Lancet Neurol. 15, 1089\u20131102 (2016).","journal-title":"Lancet Neurol."},{"key":"41960_CR14","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3389\/fpsyt.2020.00613","volume":"11","author":"SF Sonnenschein","year":"2020","unstructured":"Sonnenschein, S. F., Gomes, F. V. & Grace, A. A. Dysregulation of midbrain dopamine system and the pathophysiology of schizophrenia. Front. Psych. 11, 613 (2020).","journal-title":"Front. Psych."},{"key":"41960_CR15","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.cell.2021.01.027","volume":"184","author":"Y Zhuang","year":"2021","unstructured":"Zhuang, Y. et al. Structural insights into the human D1 and D2 dopamine receptor signaling complexes. Cell 184, 931-942. e18 (2021).","journal-title":"Cell"},{"key":"41960_CR16","doi-asserted-by":"publisher","first-page":"14651","DOI":"10.1038\/s41598-020-70732-5","volume":"10","author":"E Schmidt","year":"2020","unstructured":"Schmidt, E. et al. Changes of central noradrenaline transporter availability in immunotherapy-na\u00efve multiple sclerosis patients. Sci. Rep. 10, 14651 (2020).","journal-title":"Sci. Rep."},{"key":"41960_CR17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11293","author":"AM San Hernandez","year":"2020","unstructured":"San Hernandez, A. M. et al. Multiple sclerosis and serotonin: Potential therapeutic applications. Cureus https:\/\/doi.org\/10.7759\/cureus.11293 (2020).","journal-title":"Cureus"},{"key":"41960_CR18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.expneurol.2015.11.010","volume":"277","author":"K Ohl","year":"2016","unstructured":"Ohl, K., Tenbrock, K. & Kipp, M. Oxidative stress in multiple sclerosis: Central and peripheral mode of action. Exp. Neurol. 277, 58\u201367 (2016).","journal-title":"Exp. Neurol."},{"key":"41960_CR19","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s12035-016-9717-5","volume":"54","author":"V Lieberknecht","year":"2017","unstructured":"Lieberknecht, V. et al. Pramipexole, a dopamine D2\/D3 receptor-preferring agonist, prevents experimental autoimmune encephalomyelitis development in mice. Mol. Neurobiol. 54, 1033\u20131045 (2017).","journal-title":"Mol. Neurobiol."},{"key":"41960_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1124\/jpet.116.237503","volume":"360","author":"S Salim","year":"2017","unstructured":"Salim, S. Oxidative stress and the central nervous system. J. Pharmacol. Exp. Ther. 360, 201\u2013205 (2017).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"41960_CR21","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.bbadis.2015.09.018","volume":"1862","author":"H Lassmann","year":"2016","unstructured":"Lassmann, H. & van Horssen, J. Oxidative stress and its impact on neurons and glia in multiple sclerosis lesions. Biochim. Biophys. Acta (BBA) Mol. Basis Disease 1862, 506\u2013510 (2016).","journal-title":"Biochim. Biophys. Acta (BBA) Mol. Basis Disease"},{"key":"41960_CR22","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nrendo.2017.69","volume":"13","author":"K Chachlaki","year":"2017","unstructured":"Chachlaki, K., Garthwaite, J. & Prevot, V. The gentle art of saying NO: How nitric oxide gets things done in the hypothalamus. Nat. Rev. Endocrinol. 13, 521\u2013535 (2017).","journal-title":"Nat. Rev. Endocrinol."},{"key":"41960_CR23","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S1474-4422(02)00102-3","volume":"1","author":"KJ Smith","year":"2002","unstructured":"Smith, K. J. & Lassmann, H. The role of nitric oxide in multiple sclerosis. Lancet Neurol. 1, 232\u2013241 (2002).","journal-title":"Lancet Neurol."},{"key":"41960_CR24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jns.2010.03.024","volume":"294","author":"M Roghani","year":"2010","unstructured":"Roghani, M. et al. Concentrations of nitric oxide metabolites in the serum of Iranian multiple sclerosis patients. J. Neurol. Sci. 294, 92\u201394 (2010).","journal-title":"J. Neurol. Sci."},{"key":"41960_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.trf.2024.04.004","volume":"103","author":"H Atici-Ulusu","year":"2024","unstructured":"Atici-Ulusu, H., Taskapilioglu, O. & Gunduz, T. A neuroergonomics approach to investigate the mental workload of drivers in real driving settings. Transp. Res. F Traffic Psychol. Behav. 103, 177\u2013189 (2024).","journal-title":"Transp. Res. F Traffic Psychol. Behav."},{"key":"41960_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ejmech.2015.06.020","volume":"101","author":"AG Banerjee","year":"2015","unstructured":"Banerjee, A. G., Das, N., Shengule, S. A., Srivastava, R. S. & Shrivastava, S. K. Synthesis, characterization, evaluation and molecular dynamics studies of 5, 6\u2013diphenyl\u20131, 2, 4\u2013triazin\u20133 (2H)\u2013one derivatives bearing 5\u2013substituted 1, 3, 4\u2013oxadiazole as potential anti\u2013inflammatory and analgesic agents. Eur. J. Med. Chem. 101, 81\u201395 (2015).","journal-title":"Eur. J. Med. Chem."},{"key":"41960_CR27","doi-asserted-by":"publisher","first-page":"909","DOI":"10.31925\/farmacia.2018.5.24","volume":"66","author":"M Faheem","year":"2018","unstructured":"Faheem, M., Khan, A.-U., Nadeem, H. & Ali, F. Computational and pharmacological evaluation of heterocyclic 1, 3, 4-oxadiazole and pyrazoles novel derivatives for toxicity assessment, tumour inhibition, antioxidant, analgesic and anti-inflammatory actions. Farmacia 66, 909\u2013919 (2018).","journal-title":"Farmacia"},{"key":"41960_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2021.671212","volume":"9","author":"T Anthwal","year":"2022","unstructured":"Anthwal, T. & Nain, S. 1, 3, 4-thiadiazole scaffold: As anti-epileptic agents. Front. Chem. 9, 671212 (2022).","journal-title":"Front. Chem."},{"key":"41960_CR29","volume":"24","author":"A Bukhari","year":"2021","unstructured":"Bukhari, A., Nadeem, H., Imran, M. & Muhammad, S. A. Novel oxadiazole derivatives as potent inhibitors of \u03b1-amylase and \u03b1-glucosidase enzymes: Synthesis, in vitro evaluation, and molecular docking studies. Iran. J. Basic Med. Sci. 24, 1632 (2021).","journal-title":"Iran. J. Basic Med. Sci."},{"key":"41960_CR30","doi-asserted-by":"crossref","unstructured":"Zainab, S. R., Khan, J. Z., Nadeem, H., Tipu, M. K. & Irshad, N. Safety assessment of novel oxadiazole derivatives in acute and sub-acute toxicity studies. Naunyn-Schmiedeberg\u2019s Arch. Pharmacol. 1\u201323 (2024).","DOI":"10.1007\/s00210-024-03474-0"},{"key":"41960_CR31","doi-asserted-by":"publisher","first-page":"8404","DOI":"10.1007\/s12035-016-0333-1","volume":"54","author":"Q-C Kan","year":"2017","unstructured":"Kan, Q.-C. et al. Matrine treatment blocks NogoA-induced neural inhibitory signaling pathway in ongoing experimental autoimmune encephalomyelitis. Mol. Neurobiol. 54, 8404\u20138418 (2017).","journal-title":"Mol. Neurobiol."},{"key":"41960_CR32","doi-asserted-by":"crossref","unstructured":"Kraeuter, A.-K., Guest, P. C. & Sarnyai, Z. The open field test for measuring locomotor activity and anxiety-like behavior. Pre-clinical Models: Techniques And Protocols 99\u2013103 (2019a).","DOI":"10.1007\/978-1-4939-8994-2_9"},{"key":"41960_CR33","doi-asserted-by":"crossref","unstructured":"Kraeuter, A.-K., Guest, P. C. & Sarnyai, Z. 2019b. The Y-maze for assessment of spatial working and reference memory in mice. In Pre-clinical Models: Techniques and Protocols 105\u2013111 (2019b).","DOI":"10.1007\/978-1-4939-8994-2_10"},{"key":"41960_CR34","doi-asserted-by":"crossref","unstructured":"Lueptow, L. M. Novel object recognition test for the investigation of learning and memory in mice. J. Visual. Exp.: JoVE 55718 (2017).","DOI":"10.3791\/55718"},{"key":"41960_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-025-04486-9","volume":"50","author":"JZ Khan","year":"2025","unstructured":"Khan, J. Z. et al. Chrysophanol attenuates cognitive impairment, neuroinflammation, and oxidative stress by TLR4\/NF\u03baB-Nrf2\/HO-1 signaling in ethanol-induced neurodegeneration. Neurochem. Res. 50, 255 (2025).","journal-title":"Neurochem. Res."},{"key":"41960_CR36","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0304-4165(79)90289-7","volume":"582","author":"MS Moron","year":"1979","unstructured":"Moron, M. S., Depierre, J. W. & Mannervik, B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim. Biophys. Acta (BBA)- General Subjects 582, 67\u201378 (1979).","journal-title":"Biochim. Biophys. Acta (BBA)- General Subjects"},{"key":"41960_CR37","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1007\/s10787-025-01676-3","volume":"33","author":"MU Mazhar","year":"2025","unstructured":"Mazhar, M. U. et al. Bacillus subtilis (NMCC-path-14) ameliorates acute phase of arthritis via modulating NF-\u03baB and Nrf-2 signaling in mice model. Inflammopharmacology 33, 1863\u20131877 (2025).","journal-title":"Inflammopharmacology"},{"key":"41960_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1446304","volume":"15","author":"JZ Khan","year":"2024","unstructured":"Khan, J. Z. et al. Chrysophanol attenuates cognitive impairment, neuroinflammation, and oxidative stress by TLR4\/NF\u03baB-Nrf2\/HO-1 and BDNF\/VEGF signaling in stress-intensified PTZ induced epilepsy in mice. Front. Pharmacol. 15, 1446304 (2024).","journal-title":"Front. Pharmacol."},{"key":"41960_CR39","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa, H., Ohishi, N. & Yagi, K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95, 351\u2013358 (1979).","journal-title":"Anal. Biochem."},{"key":"41960_CR40","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jchromb.2006.07.054","volume":"851","author":"D Tsikas","year":"2007","unstructured":"Tsikas, D. Analysis of nitrite and nitrate in biological fluids by assays based on the Griess reaction: Appraisal of the Griess reaction in the L-arginine\/nitric oxide area of research. J. Chromatogr. B 851, 51\u201370 (2007).","journal-title":"J. Chromatogr. B"},{"key":"41960_CR41","doi-asserted-by":"publisher","first-page":"915595","DOI":"10.3389\/fphar.2022.915595","volume":"13","author":"MU Rehman","year":"2022","unstructured":"Rehman, M. U. et al. Probiotics (Bacillus clausii and Lactobacillus fermentum NMCC-14) ameliorate stress behavior in mice by increasing monoamine levels and mRNA expression of dopamine receptors (D1 and D2) and synaptophysin. Front. Pharmacol. 13, 915595 (2022).","journal-title":"Front. Pharmacol."},{"key":"41960_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jchromb.2017.04.003","volume":"1055","author":"SL Zandy","year":"2017","unstructured":"Zandy, S. L., Doherty, J. M., Wibisono, N. D. & Gonzales, R. A. High sensitivity HPLC method for analysis of in vivo extracellular GABA using optimized fluorescence parameters for o-phthalaldehyde (OPA)\/sulfite derivatives. J. Chromatogr. B 1055, 1\u20137 (2017).","journal-title":"J. Chromatogr. B"},{"key":"41960_CR43","doi-asserted-by":"crossref","unstructured":"Peter, S. C., Dhanjal, J. K., Malik, V., Radhakrishnan, N., Jayakanthan, M., Sundar, D., Sundar, D. & Jayakanthan, M. Encyclopedia of bioinformatics and computational biology. (eds Ranganathan, S., Grib-skov, M., Nakai, K. & Sch\u00f6nbach, C.) 661\u2013676 (2019).","DOI":"10.1016\/B978-0-12-809633-8.20197-0"},{"key":"41960_CR44","doi-asserted-by":"crossref","unstructured":"Mathur, N., Sai, S., Shandily, S., Santoki, K. M., Vadhavana, N. N., Shah, S. & Chandra, M. In silico docking: Protocols for computational exploration of molecular interactions. (2024).","DOI":"10.5772\/intechopen.1005527"},{"key":"41960_CR45","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1080\/08927022.2024.2316828","volume":"50","author":"N Ahmad","year":"2024","unstructured":"Ahmad, N. et al. Mutant anaplastic lymphoma kinase inhibitor identification by integrated in silico approaches. Mol. Simul. 50, 404\u2013419 (2024).","journal-title":"Mol. Simul."},{"key":"41960_CR46","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<490::AID-JCC1>3.0.CO;2-P","volume":"17","author":"TA Halgren","year":"1996","unstructured":"Halgren, T. A. Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J. Comput. Chem. 17, 490\u2013519 (1996).","journal-title":"J. Comput. Chem."},{"key":"41960_CR47","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/qsar.19860050305","volume":"5","author":"I Motoc","year":"1986","unstructured":"Motoc, I., Dammkoehler, R. A., Mayer, D. & Labanowski, J. Three\u2010dimensional quantitative structure\u2010activity relationships I. general approach to the pharmacophore model validation. Quant. Struct. Act. Relat. 5, 99\u2013105 (1986).","journal-title":"Quant. Struct. Act. Relat."},{"key":"41960_CR48","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1","author":"MJ Abraham","year":"2015","unstructured":"Abraham, M. J. et al. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1, 19\u201325 (2015).","journal-title":"SoftwareX"},{"key":"41960_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-0500-5-367","volume":"5","author":"AW SOUSA DA Silva","year":"2012","unstructured":"SOUSA DA Silva, A. W. & Vranken, W. F. ACPYPE-Antechamber python parser interface. BMC Res. Notes. 5, 1\u20138 (2012).","journal-title":"BMC Res. Notes."},{"key":"41960_CR50","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926\u2013935 (1983).","journal-title":"J. Chem. Phys."},{"key":"41960_CR51","doi-asserted-by":"publisher","DOI":"10.1103\/PhysRevLett.90.075503","volume":"90","author":"R Marto\u0148\u00e1k","year":"2003","unstructured":"Marto\u0148\u00e1k, R., Laio, A. & Parrinello, M. Predicting crystal structures: The Parrinello-Rahman method revisited. Phys. Rev. Lett. 90, 075503 (2003).","journal-title":"Phys. Rev. Lett."},{"key":"41960_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00374","volume":"11","author":"BL Guerrero","year":"2020","unstructured":"Guerrero, B. L. & Sicotte, N. L. Microglia in multiple sclerosis: Friend or foe? Front. Immunol. 11, 374 (2020).","journal-title":"Front. Immunol."},{"key":"41960_CR53","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1007\/s00415-010-5863-2","volume":"258","author":"M Axelsson","year":"2011","unstructured":"Axelsson, M. et al. Glial fibrillary acidic protein: A potential biomarker for progression in multiple sclerosis. J. Neurol. 258, 882\u2013888 (2011).","journal-title":"J. Neurol."},{"key":"41960_CR54","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1093\/brain\/aww172","volume":"139","author":"R Macrez","year":"2016","unstructured":"Macrez, R. et al. Neuroendothelial NMDA receptors as therapeutic targets in experimental autoimmune encephalomyelitis. Brain 139, 2406\u20132419 (2016).","journal-title":"Brain"},{"key":"41960_CR55","doi-asserted-by":"publisher","first-page":"e20201290","DOI":"10.1084\/jem.20201290","volume":"218","author":"MS Woo","year":"2021","unstructured":"Woo, M. S. et al. Neuronal metabotropic glutamate receptor 8 protects against neurodegeneration in CNS inflammation. J. Exp. Med. 218, e20201290 (2021).","journal-title":"J. Exp. Med."},{"key":"41960_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.103136","volume":"54","author":"A Olsson","year":"2021","unstructured":"Olsson, A. et al. Circulating levels of tight junction proteins in multiple sclerosis: Association with inflammation and disease activity before and after disease modifying therapy. Multiple Sclerosis Related Disorders 54, 103136 (2021).","journal-title":"Multiple Sclerosis Related Disorders"},{"key":"41960_CR57","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0165-5728(02)00372-7","volume":"133","author":"M Cosentino","year":"2002","unstructured":"Cosentino, M. et al. Catecholamine production and tyrosine hydroxylase expression in peripheral blood mononuclear cells from multiple sclerosis patients: Effect of cell stimulation and possible relevance for activation-induced apoptosis. J. Neuroimmunol. 133, 233\u2013240 (2002).","journal-title":"J. Neuroimmunol."},{"key":"41960_CR58","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0165-5728(99)00211-8","volume":"100","author":"KC Dowdell","year":"1999","unstructured":"Dowdell, K. C., Gienapp, I. E., Stuckman, S., Wardrop, R. M. & Whitacre, C. C. Neuroendocrine modulation of chronic relapsing experimental autoimmune encephalomyelitis: A critical role for the hypothalamic\u2013pituitary\u2013adrenal axis. J. Neuroimmunol. 100, 243\u2013251 (1999).","journal-title":"J. Neuroimmunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41960-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41960-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41960-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T11:01:36Z","timestamp":1783940496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41960-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["41960"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-41960-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"25 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study is reported in accordance with ARRIVE guidelines. All research procedures were carefully carried out following the guidelines of Quaid-i-Azam University for animal care and use. The bioethical committee thoroughly approved the methodology, ensuring the ethical treatment of the animals involved in the study (Approval No. #BEC-FBS-QAU2024-670).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"21696"}}